Search

Search Constraints

You searched for: Author/Creator Leong, Ruby

Search Results

3. FDA approval summary: Crizotinib for pediatric and young adult patients with relapsed or refractory systemic anaplastic large cell lymphoma. Issue 8 (13th May 2022)

4. FDA Approval Summary: Ruxolitinib for Treatment of Steroid‐Refractory Acute Graft‐Versus‐Host Disease. (22nd October 2019)